Shows
Lungcast2025 State of the Air: Dangers of the Air We Breathe with George Thurston, ScDAn internationally recognized leader in air quality, epidemiology and exposure assessment, George Thurston, ScD, of New York University headlines this important episode analyzing the Lung Association’s 2025 “State of the Air” report. With nearly half of the people living in the U.S. breathing unhealthy amounts of air pollution, Thurston delves into the acute and accumulative health impacts on communities across the country. Listen in to learn more about the report’s key learnings, from adverse effects of exposure to ground-level ozone pollution to the decade-long worsening trend of particle pollution.
Want more Lungcast? Visit us at HCPLive.com/podc...2025-05-1331 min
HCPLive PodcastsHCPLive Under 5 Audio Recap: Week of 05/04Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impacting clinicians and healthcare providers like you!
Interested in a more traditional, text rundown? Check out the HCPFive!
Top 5 Healthcare Headlines for April 28-May 4, 2025:
Obicetrapib Achieves Robust LDL-C Reductions in Phase 3 ASCVD Trials
Obicetrapib significantly reduced LDL-C as monotherapy and in combination with ezetimibe in ASCVD patients inadequately controlled by statins, according to Phase 3 data presented at EAS...2025-05-1103 min
HCPLive PodcastsHCPLive Under 5 Audio Recap: Week of 04/27Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impacting clinicians and healthcare providers like you!
Interested in a more traditional, text rundown? Check out the HCPFive!
Top 5 Healthcare Headlines for April 21-April 27, 2025:
FDA Approves Pz-cel (Zevaskyn) Gene Therapy for RDEB
The FDA has approved pz-cel, the first autologous gene therapy for RDEB, following pivotal Phase 3 data demonstrating efficacy and safety in wound healing.
FDA Approves Upad...2025-05-0404 min
HCPLive PodcastsLiver Lineup: Updates & Unfiltered Insights
Introducing Liver Lineup: Updates & Unfiltered Insights — an exciting new podcast delivering timely, candid perspectives on the most pressing topics in the fast-moving world of hepatology. Created by Nancy Reau, MD, and Kimberly Brown, MD, and hosted by HCPLive, this series dives into the cutting edge of liver disease research, clinical care, and real-world practice.
Intended for hepatologists, gastroenterologists, and other clinicians managing liver disease, Liver Lineup will unpack the latest research, debate emerging controversies, and spotlight developments that could shape — or sharpen — day-to-day practice, all with unfiltered perspective and clarity.
Brown is division chief of gastroenterology and he...2025-05-0105 minLungcastLung Cancer Screening: A Decade of Lessons Learned with Mary Pasquinelli, DNPIt has been more than a decade since lung cancer screening guidelines via low-dose CT, based on the USPSTF’s B recommendations, have been put into place. To discuss the guidelines’ ambitions and obstacles, we are joined by the University of Illinois Health System’s Mary Pasquinelli, DNP, who specializes in lung cancer, lung cancer screening and pulmonary nodule management. While a lifesaving procedure for at-risk individuals, the uptake of screening on a population-level—though increasing—has been slower than expected.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
2025-04-2335 min
Skin of Color Savvy: The Art and Science of Treating Patients of ColorSkin of Color Savvy: New Update—Discussing the AAD Clinical Image CollectionIn this special news update edition of Skin of Color Savvy: The Art and Science of Treating Patients of Color, Vinod Nambudiri, MD, MBA, MPH, speaks with the HCPLive team on the floor of the 2025 American Academy of Dermatology (AAD) Annual Meeting to discuss a groundbreaking new initiative—the AAD Clinical Image Collection. Nambudiri, a medical dermatologist, an associate professor of dermatology and internal medicine at Harvard Medical School, and the program director for the Harvard Combined Dermatology Program, shares how this newly launched image repository aims to close longstanding gaps in dermatologic education and representation.2025-04-2206 minHCPLive PodcastsHCPLive Under 5 Audio Recap: Week of 04/06Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impacting clinicians and healthcare providers like you!
Interested in a more traditional, text rundown? Check out the HCPFive!
Top 5 Healthcare Headlines for March 31-April 6, 2025:
Cedars-Sinai Study Finds AI Tool Could Improve Care in Virtual Urgent Care Settings
A Cedars-Sinai study suggests AI tools may enhance guideline adherence and decision-making quality in virtual urgent care, though clinician oversight remains essential.
...2025-04-1303 minHCPLive PodcastsHCPLive Under 5 Audio Recap: Week of 03/16Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impacting clinicians and healthcare providers like you!
Interested in a more traditional, text rundown? Check out the HCPFive!
Top 5 Healthcare Headlines for March 23-30, 2025:
Zetomipzomib Shows Promise for Autoimmune Hepatitis in Phase 2a PORTOLA Trial
Zetomipzomib demonstrated steroid-sparing biochemical remissions in refractory autoimmune hepatitis patients, aligning with AASLD treatment guidelines in the Phase 2a PORTOLA trial.
...2025-03-2804 min
Skin of Color Savvy: The Art and Science of Treating Patients of ColorSkin of Color Savvy: News Update—Debunking Myths and Highlighting the SOCS SymposiumSkin of Color Savvy: The Art and Science of Treating Patients of Color—produced by HCPLive in collaboration with the Skin of Color Society—explores the latest research, clinical advancements, and culturally competent care practices in dermatology. Featuring Mojgan Hosseinipour, DO, FAAD, a board-certified dermatologist and clinical research investigator, this episode addresses key dermatological concerns among patients of color, misconceptions in skin health, and the importance of diversity in clinical research.
Key Timestamps
00:00 Introductions
01:06 Misconceptions regarding alopecia
02:58 Recent research involvement
05:21 SOCS Symposium
06:07 Dr. Elbuluk interview
07:51 Dr. Aguh...2025-03-2709 minHCPLive PodcastsHCPLive Under 5 Audio Recap: Week of 03/16Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impacting clinicians and healthcare providers like you!
Interested in a more traditional, text rundown? Check out the HCPFive!
New ACP Guidelines Recommend Adding Triptan to NSAID or Acetaminophen for Migraines
The American College of Physicians now recommends adding a triptan to NSAIDs or acetaminophen for moderate to severe acute migraines and urges clinicians to initiate combination therapy early.
Auto...2025-03-2303 minHCPLive PodcastsHCPLive Under 5 Audio Recap: Week of 03/09Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impacting clinicians and healthcare providers like you!
Interested in a more traditional, text rundown? Check out the HCPFive!
Top 5 healthcare headlines for March 9-16, 2025:
1. CagriSema Yields Nearly 16% Weight Loss in Phase 3 REDEFINE 2 Trial
In the Phase 3 REDEFINE 2 trial, CagriSema showed weight reduction in adults with obesity or overweight and type 2 diabetes, outperforming placebo.
2. Lorundrostat Significantly Lowers Bloo...2025-03-1603 min
HCPLive PodcastsNew Insight: A Deep Dive into the Oculis Pipeline with Riad Sherif, MDVideo version available on HCPLive!
In this episode of New Insight, host Veeral Sheth, MD, MBA, director of clinical research at University Retina and Macula Associates, speaks with Riad Sherif, MD, chief executive officer of Oculis, about the company's groundbreaking advancements in ophthalmic therapeutics.
The discussion delves into Oculis' clinical pipeline, particularly OCS-05, a neuroprotective agent demonstrating promising results in acute optic neuritis. The Phase 2 ACUITY trial showed that OCS-05 preserved retinal ganglion cells (RGCs), reduced axonal loss, and improved low-contrast visual acuity. Importantly, patients receiving OCS-05 experienced significantly fewer multiple sclerosis relapses, suggesting broader neuroprotective...2025-03-0527 minLungcastAfter the Smoke: Wildfire Cleanup & Air Quality Concerns with Afif El-Hasan, MDFor this hot topic, asthma and lung health expert Dr. Afif El-Hasan of Kaiser Permanente in California joins host Dr. Albert Rizzo to discuss the acute effects of wildfire smoke on air quality. The enlightening conversation also covers the massive cleanup efforts from the recent Los Angeles wildfires and how related exposures may pose health risks.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
2025-02-2414 min
HCPLive PodcastsHCPLive 5 Stories in Under 5: Week of 02/16Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impacting clinicians and healthcare providers like you!
Interested in a more traditional, text rundown? Check out the HCPFive!
Top 5 healthcare headlines for February 16 - 23, 2025:
1. Sotagliflozin Cuts MACE Risk By 23% in Patients with Type 2 Diabetes, CKD
Dual SGLT1/2 inhibition with sotagliflozin significantly reduced both heart attacks and stroke in a prespecified secondary analysis of the SCORED trial.
2. Nebo...2025-02-2403 min
Skin of Color Savvy: The Art and Science of Treating Patients of ColorPigmentary Disorders in Skin of Color, with Nada Elbuluk, MD, MSc, and Michelle Rodrigues, MBBS
Welcome to Skin of Color Savvy: The Art and Science of Treating Patients of Color!
In episode 2 of Skin of Color Savvy, host Nada Elbuluk, MD, chats with pigmentary disorder expert Michelle Rodrigues, MBBS, about diagnosing and managing conditions like melasma, vitiligo, and post-inflammatory hyperpigmentation in diverse populations. They discuss key diagnostic tools, systemic associations, and emerging therapies, including non-hydroquinone agents, picosecond lasers, and JAK inhibitors. The episode highlights the importance of comprehensive photoprotection, culturally competent care, and personalized treatment strategies to improve outcomes and address unique challenges in skin of color dermatology.
Video Version only...2025-02-0320 min
HCPLive PodcastsNew Insight: A Look at Qlosi for Presbyopia with Elad Kedar, MBA
Video Version Available on YouTube!
In this episode of New Insight, host Veeral Sheth, MD, MBA, director of clinical research at University Retina and Macula Associates, explored the approval and impending launch of Qlosi (pilocarpine HCL ophthalmic solution) 0.4%, a groundbreaking pharmacologic option for managing presbyopia, with Elad Kedar, MBA, chief executive officer of Orasis Pharmaceuticals.
A condition that affects nearly all adults as they age, presbyopia is characterized by the gradual loss of near vision due to reduced lens elasticity. Sheth and Kedar highlighted the significance of finding non-invasive treatment options for this pervasive issue, given...2025-01-2828 min
LungcastRace-Neutral Approach to Pulmonary Function Testing with Meredith McCormack, MD, and Loretta Que, MDIn this episode, Dr. Meredith McCormack of Johns Hopkins University and Dr. Loretta Que of Duke University to discuss “race-based normal values” in medicine, particularly in regard to pulmonary function tests (PFT).
The controversial practice of using a patient’s self-reported race to adjust a standard “normal” range has been shown to lead to potential misdiagnosis and healthcare disparities. Drs. McCormack and Que talk at length about their key roles in the growing movement to phase out a reliance on race in PFT interpretation.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/p...2025-01-2720 min
LungcastThis Year in Pulmonology: The 2024 Lungcast RecapEver since the show first launched, Lungcast has provided pulmonologists and health care providers in general a chance to take part in ongoing conversations regarding lung health between experts, patients, and patient advocates.
In this recap episode, the Lungcast team reflects on these conversations by highlighting some of the many interviews featured in 2024. The following are a set of examples of this year’s interviews, though several other memorable episodes are not on this list. We hope you enjoy this set of highlights.
For more, view a summary here: https://www.hcplive.com/view/this-year-in-pulmonology-a-2024-lungcast-recap2025-01-1018 min
Skin of Color Savvy: The Art and Science of Treating Patients of ColorItch in Skin of Color, with Andrew Alexis, MD, MPH, and Shawn Kwatra, MDWelcome to Skin of Color Savvy: The Art and Science of Treating Patients of Color, the official podcast of the Skin of Color Society, produced by HCPLive. Hosted by Skin of Color Society (SOCS) leaders, this podcast delves into the latest research, clinical insights, and culturally competent care practices in dermatology. From groundbreaking studies to practice-changing insights, we’re here to empower healthcare providers with expert perspectives on treating patients with skin of color.
In this, the podcast’s inaugural episode, SOCS board members Andrew Alexis, MD, MPH, vice chair for Diversity and Inclusion for the Department of Derm...2025-01-0617 min
Lungcast2024 State of Lung Cancer: The Hopes and Hurdles of Precision Oncology with Dr. Jacob SandsFor a probing discussion detailing the American Lung Association’s recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targeted mutations, Dr. Sands addresses how precision oncology is fundamentally changing lung cancer diagnosis and treatment.
The novel immunotherapy drugs, though proven to be safe and effective with significant improvements in response and survival rates, have challenges as well—this episode covers the gamut.
Episode Highlights
0:00 Start
1:00 Topic of discussion
2:42 Introducing Jacob Sa...2024-12-0833 min
LungcastPhysician, Patient & Partner Perspectives on AERD with Dr. Mitchell Grayson, Rhonda Nelson & Wayne NelsonIn this episode, multiple points of view are presented regarding Asthma Exacerbated Respiratory Disease (AERD). Lungcast host Albert Rizzo, MD, was joined by allergist and immunologist Mitchell Grayson, MD, of Nationwide Children’s Hospital, as well as patient advocate Rhonda Nelson and her husband Wayne Nelson of The Little River Band. This discussion delves into the trials and tribulations of diagnosing—and living with—AERD, from disease misconceptions to daily management.
Join the discussion as these guests focus specifically on the role of AI in chest imaging and uncover how these advancements are improving the future of patient care.2024-11-1328 minLungcastThe Quest to Intercept Lung Disease with Drs. Ravi Kalhan, Amy Olson & George Washko
Episode Highlights
0:15 Intro
1:10 Introducing the Lung Health Cohort Research Study
3:49 The enrollment strategy
7:10 Seeking “the cholesterol of lung disease”
11:50 The role of industry support
14:09 Imaging strategies for long-term lung assessment
17:59 Recruitment challenges
23:05 Final thoughts
26:20 Outro
For our 50th episode, Ravi Kalhan, MD, of Northwestern Medicine, George Washko, MD, of Harvard University, and Amy Olson, MD, Executive Director of Medical Affairs for Boehringer Ingelheim Pharmaceuticals, Inc, join us for a panel discussion around improving patient outcomes through innovative lung health research, such as with the American Lung Association Lung Health Coho...2024-10-2926 minLungcastLung Imaging 2.0: How AI is Shaping the Future with Dr. Rachel EddyIn this episode, Dr. Rachel Eddy of the University of British Columbia explores the evolving field of medical imaging technology and the transformative impact of artificial intelligence. While applications of AI have expanded beyond traditional radiology, it delves into cutting-edge techniques like 3D printing and molecular imaging that are redefining diagnostics and treatment planning.
Join us as we focus specifically on the role of AI in chest imaging and uncover how these advancements are improving the future of patient care.
Episode Highlights
0:15 Intro
1:10 The history of medical imaging technology
3:02 Artificial intelligence terminology
8:56...2024-09-3032 minLungcastPrepare Your Lungs for Back-to-School with Juanita Mora, MD & S. Christy Sadreameli, MD
Episode Highlights
0:16 Intro
2:24 Asthma action plans
3:52 Asthma Peak Week
6:28 School nurse’s role
11:05 SMART inhaler strategy for kids
14:25 Addressing vaping among students
20:18 Discussing vaccines with children and parents
24:01 School air quality issues?
27:50 Final thoughts
29:42 Outro
As families jump into the new school year, this episode brings together Chicago-based allergist and immunologist Dr. Juanita Mora and pediatric pulmonologist Dr. S. Christy Sadreameli of Johns Hopkins Hospital to share their tips for making the return to school as smooth as possible in regard to lung health.
The liv...2024-08-1230 minLungcastThe Health Consequences of Climate Change with Janelle Bludorn, PA-C, MS
Episode Highlights
0:15 Introduction
2:35 Introducing Janelle Bludorn, MS, PA-C
3:27 Common heat-related illnesses
8:43 How to screen for individual health-related risks
15:27 Respiratory consequences of heat
19:49 The interplay of medicines with heat
26:49 National Weather Service HeatRisk tool
32:58 Behavioral interventions for heat-risk patients
36:27 A FEMA system for heat emergencies?
38:10 Outro
For our July episode, we are visited by Duke University’s Janelle Bludorn, PA-C, MS, for a comprehensive overview of heat-related respiratory illnesses.
Due to climate change in all regions around the world, extreme heat has become a significant environmental and occ...2024-07-2238 min
HCPLive PodcastsFDA First Half Recap: Dermatology in 2024Led by a flood of biologic therapies becoming available and progressing within the therapeutic pipeline, the field of dermatology finds itself in the midst of a watershed moment for many dermatologic conditions. To celebrate and recap the advancements occurring in the first half of 2024, the editorial team of HCPLive Dermatology sat down with James Del Rosso, DO, research director of JDR Dermatology Research and president of the American Acne and Rosacea Society, for more perspective on pipeline movement.
Del Rosso, who also serves as an adjunct clinical professor of Dermatology at Touro University, takes a deep dive into...2024-07-0440 min
HCPLive PodcastsNew Insight: A Look at Gildeuretinol (ALK-001) for Stargardt Disease w/ Seemi Khan, MDIn the latest episode of New Insight with Veeral Sheth, MD, host Veeral Sheth, MD, director of clinical research at University Retina, speaks with Seemi Khan, chief medical officer at Alkeus Pharmaceuticals, on the company’s lead candidate being evaluated in clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Gildeuretinol is a novel molecule designed as a specialized form of deuterated vitamin A to reduce the dimerization of vitamin A without disrupting vision. The therapy has received Breakthrough and Orphan Drug designations from the US Food and Drug Ad...2024-07-0321 minHCPLive PodcastsNew Insight: A Look at Gildeuretinol (ALK-001) for Stargardt Disease w/ Seemi Khan, MDIn the latest episode of New Insight with Veeral Sheth, MD, host Veeral Sheth, MD, director of clinical research at University Retina, speaks with Seemi Khan, chief medical officer at Alkeus Pharmaceuticals, on the company’s lead candidate being evaluated in clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Gildeuretinol is a novel molecule designed as a specialized form of deuterated vitamin A to reduce the dimerization of vitamin A without disrupting vision. The therapy has received Breakthrough and Orphan Drug designations from the US Food and Drug Adm...2024-07-0223 minLungcastStopping Lung Cancer Before It Starts with Drs. Steven Dubinett & Avrum Spira
Episode Highlights
0:15 Intro
3:39 Update in pre-lung cancer genome atlas research
17:06 Next steps: applying innovations in bronchoscopy
21:45 When we can anticipate results
25:05 Understanding the lung’s microbiome
29:21 Utility of fragmentomics
31:01 Outro
Dr. Steven Dubinett at University of California, Los Angeles and Dr. Avrum Spira at Boston University revisit our virtual studio to provide an update on their lung cancer interception research, as currently funded by the American Lung Association and LUNGevity Foundation. With the goal of combating cancer at a preliminary stage, Drs. Dubinett and Spira are focused on refining molecular and im...2024-06-2432 minHCPLive PodcastsNew Insight: A Look at the OcuLenz with Michael Freeman, CEO of OcutrxSince the mid-20th century ushered in the ‘Information Age’, a desire for innovation has driven the pursuit of technological advancements. Many may immediately consider the transformations personal computers and smartphones have had on modern society, but these advancements have transformed the fields of medicine time and time again.
In the latest episode of New Insight with Veeral Sheth, MD, Michael Freeman, the chief executive officer of Ocutrx, joins Dr. Sheth to discuss the history of Ocutrx, its OcuLez and OR-Bot products, and what he envisions in the next decade at the company.
Episode Highlights
0:06 Intr...2024-06-1129 minLungcastChanging Landscape of Community-Acquired Pneumonia with Dr. Thomas File
0:16 Intro
2:29 Updated community-acquired pneumonia guidelines
5:41 Diagnostic tools for CAP following COVID-19
9:35 Procalcitonin levels as a biomarker
12:30 The CAP treatment algorithm
18:36 Best practices for antibiotic stewardship
20:40 New CAP therapies on the horizon
22:36 ACIP recommendations for vaccination
24:30 Remaining areas of CAP uncertainty
26:30 Final thoughts
27:25 Outro
Featuring infectious disease expert Dr. Thomas File of Summa Health in Ohio, this episode delves into how community-acquired pneumonia has been affected by the COVID-19 pandemic. It additionally covers the role and importance of antibiotic stewardship and the concern of ‘superbugs’ due to antimicrobial resistance.
...2024-06-0627 minLungcastMultidisiplinary Asthma Care in High-Risk Communities with Stephanie Lovinsky-Desir, MD, MS
Episode Highlights
0:11 Intro
1:05 Introducing Stephanie Lovinsky-Desir, MD, MS
2:09 Understanding asthma endotypes and phenotypes
5:03 The effect of SMART guideline updates
11:50 Are pulmonary & allergy specialists adopting it?
12:46 The value of biologics in asthma care
18:11 Could they interrupt the atopic march?
19:53 COVID-19 risks in asthma
23:24 Environmental and non-viral illness impacts on asthma
26:11 Research into asthma care inequities
31:47 HFA-containing metered dose inhalers
35:37 Outro
In honor of World Asthma Day, Dr. Stephanie Lovinsky-Desir of Columbia University Irving Medical Center in New York visits our virtual studio to talk about all...2024-05-0736 minLungcast2024 State of the Air: Record Highs in US Particle Pollution, with Dr. John Balmes
Episode Highlights
0:16 Intro
2:17 What caused the particle pollution spike?
6:28 The health effects of fine particle pollution exposure
10:23 The new EPA particle pollution standard
14:27 Improvements to ozone pollution and the Clean Air Act
18:46 How to advocate for improvement
20:23 Air quality inequity
24:03 Reflecting on 25 years, and looking ahead
25:52 Outro
Dr. John Balmes, a renowned environmental health sciences expert from the University of California, San Francisco, join Lungcast for a deep dive into the American Lung Association’s newly released 2024 “State of the Air” report. Balmes specifically provides context behind several concerning trends...2024-04-2427 minLungcastLung Allocation System: Improving Patient Access with Kenneth McCurry, MD & Maryam Valapour, MD, MPP
0:16 Intro
2:28 Recent modifications to the lung allocation score
5:11 Monitoring chronic graft rejection
9:23 The rising use of ex vivo lung perfusion
16:17 The presence of post-COVID patients on the lung transplant waitlist
21:01 Impact of long Covid on transplant rehabilitation
22:51 Double lung transplant in bilateral lung cancer—what’s the future?
26:52 Effect of LAS on lung transplant survival racial disparity
31:05 What lies ahead in the practice of lung transplantation
35:00 Outro
Cleveland Clinic’s Maryam Valapour, MD, MPP, rejoins the broadcast, along with her colleague Kenneth McCurry, MD to discuss optimization of the lung al...2024-04-0235 min
HCPLive PodcastsAndrew F. Alexis, MD, MPH: Discussing Controversies in Acne, Rosacea
Episode Highlights:
0:16 Intro
0:28 Overview of presentation
0:38 Acne and post-inflammatory hyperpigmentation
01:35 Approaches to take
03:21 Rosacea, use of dermoscopy and symptomatology assessment
04:59 Necessity of inclusivity in clinical trials, other knowledge gaps
06:05 Images used in education
The American Academy of Dermatology (AAD) Annual Meeting in 2024 featured Dr. Andrew Alexis, a prominent figure in dermatology. Dr. Alexis, currently serving as the vice-chair for diversity in the department of dermatology and a professor of clinical dermatology at Weill Cornell Medical College in New York, presented a talk titled "...2024-03-1408 min
HCPLive PodcastsNew Insight: Role of Contract Research Organizations in Retina w/ Brad DoerschukIn the medical community, a revolving cast of players plays a pivotal role in advancing scientific discovery and enhancing patient outcomes. During the research stage, a collaborative team effort, from the clinical trial sponsors to research sites and patient populations, is essential to ensure smooth progress and sustain momentum toward the finish line.
The latest episode of New Insight with Veeral Sheth, MD features a conversation with Brad Doerschuk, the CEO of InFocus Clinical Research, on the important role of contract research organizations (CROs) in retina and the field of ophthalmology.
In their conversation, Sheth and D...2024-03-0129 minLungcastThe Promise of Lung Cancer Precision Medicine with Dr. Jonathan Spicer
Episode Highlights
0:15 Intro
3:09 Low-dose CT screening uptake in Canada
4:45 Evolution of adjuvant, neoadjuvant therapies
7:10 Reviewing CheckMate 816
10:56 Reviewing KEYNOTE-671
12:58 The impact of neoadjuvants on operability
16:15 Treatment-specific biomarkers for lung cancer
21:13 The short-term future of lung cancer therapy
24:31 Outro
Precision medicine–delivering the right drug at the right time to the right patient–is the direction in which lung cancer treatment is heading. In this episode, we talk about an exciting, emerging drug class with one of the most prominent investigators involved with its development, Dr. Jonathan Spicer at McGill University’s Thor...2024-02-1225 min
HCPLive PodcastsNew Insight: Reengaging the Retina Community in 2024 w/ David Eichenbaum, MD and Roger Goldberg, MDA special double-episode of New Insight with Veeral Sheth, MD features a well-rounded conversation on all things ophthalmology with returning guest David Eichenbaum, MD, the director of research for Retina Vitreous Associates of Florida, as well as first-time guest Roger Goldberg, MD, a vitreoretinal surgeon at Bay Area Retina Associates.
The trio of retina specialists discuss recent conference news, the anniversary of a landmark agent, and what’s to come in 2024 for the specialty.
Episode Highlights:
0:00 Introduction
1:25 Entering 2024
7:34 The importance of treatment efficacy
12:09 Re-engaging GA treatment
15:05 Comparing aflibercept 8 mg and faricimab2024-02-1240 minLungcastReflecting on the 1964 Surgeon General Report with Viet Le, DMSc, PA-C
Episode Highlights
0:15 Intro
1:48 Remembering the 1964 Surgeon General Report
3:01 The impact of the report on cardiology
6:47 The strategies and impact of anti-smoking campaigns
10:33 The modern vaping challenge
17:38 Outro
In recognition of 60 years since the 1964 Surgeon General Report—a historic contribution to our understanding of the negative health impacts of cigarette smoking—host Albert Rizzo, MD, meets with preventive cardiology expert Viet Le, DMSc, PA-C to reflect on the myriad of cascading effects delivered by this landmark report.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org...2024-01-2918 minLungcastThe Health Crisis of Physician Burnout with Dr. Sue Padernacht
Episode Highlights
0:15 Introducing Sue Padernacht, EDd, PCC
1:16 The definition of burnout
3:53 The history of burnout
7:45 Differences between stress and burnout
14:34 Physical and behavioral signs of burnout
20:55 Steps the health care industry can take against burnout
We are beginning 2024 with a matter that extends beyond the confines of pulmonary medicine and really has become something of a crisis in the U.S. healthcare system over the last decades. Organizational psychology expert Dr. Sue Padernacht joins Lungcast to provide an in-depth look into physician burnout—what are its drivers, what factors are exacerbating it, an...2024-01-1131 min
HCPLive PodcastsNew Insight: A Look at APX3330 for Diabetic Retinopathy with George Magrath, MDIn every episode of New Insight, Veeral Sheth, MD, Director of Clinical Trials at University Retina in Chicago, takes an in-depth look at the biggest news in ophthalmology and the behind the scenes work involved in eye care, with a rotation of guest experts involved in ophthalmic research, development, and clinical care.
The latest episode of New Insight features a conversation with Ocuphire Pharma’s CEO on the company’s flagship retinal product and leading a small, but high-powered research team.
Episode Highlights:
0:04 Introduction
1:23 History of Ocuphire Pharma
3:50 Leading a small, high-functioning team
...2023-12-1821 minLungcastThis Year in Medicine: Lungcast 2023 Recap
Episode Highlights
0:16 Intro
1:44 How to approach stage IV lung cancer, with Dr. David Tom Cooke
4:13 The ALA Lung Health Cohort Research Study, with Dr. Ravi Kalhan
8:42 What is the atopic march, with Dr. Payel Gupta
10:53 Weight loss for asthma care, with Dr. Anne Dixon
15:11 Air Quality Index 101, with Dr. Al Rizzo
18:47 Lung Cancer Age Equity, with Dr. Carolyn Presley
21:45 The emerging treatments for long Covid, with Dr. Julia Moore Vogel
24:28 The future of pulmonary embolism care, with Dr. Parth Rali
28:08 The modern fight against RSV, with Dr. Barbara Taylor2023-12-1339 minLungcastWhy Good Indoor Air Quality Matters with Mark Hernandez, PhD, PEFor this episode fully focused on indoor air pollution, we are joined by Professor Mark Hernandez who serves as director of the Aerobiology and Disinfection Lab at the University of Colorado. Listen in to learn about the harmful impact of pollutants such as mold, toxic chemicals and asbestos on respiratory health, particularly in a school setting. Equally important, what can be done to help alleviate these effects?
Episode highlights
0:16 Intro
0:50 Introducing Mark Hernandez, PhD, PE
2:15 The most pressing issues of school air quality
4:12 Advice for school administrators
6:25 The link to pediatric asthma2023-12-0424 minLungcastLung Cancer Patient Perspective with Christy FischerChristy Fischer, a miraculous 17-year stage IV lung cancer survivor, connects with us to discuss stress, stigma and significant changes in the treatment landscape. Hear how Christy transformed a daunting diagnosis into hope for others.
This educational and inspirational episode touches upon the raw emotions of what it is like to live (and thrive!) with advanced cancer.
Episode Highlights
0:17 Intro
1:55 Christy's first diagnosis
3:53 Reacting to Stage IV lung cancer
5:28 Initiating treatment
7:18 The lung cancer stigma
9:51 Finding the right doctor
11:16 How lung cancer care changed over 17 years
14:20 Clinical trial...2023-11-0624 min
HCPLive PodcastsAutoimmune Hepatitis at ACG 2023, with Gina Choi, MDEpisode Highlights
0:12 Intro
1:24 Challenges in autoimmune hepatitis
3:30 Patient demographics
4:25 Diagnostic challenges
6:35 What is overlap syndrome?
8:04 Mysteries behind immune dysregulation
9:05 Promising drugs in investigation
10:51 The BAFF receptor target
11:41 Infliximab & rituximab
12:38 An autoimmune hepatitis wishlist
15:29 Outro
Autoimmune hepatitis (AIH), a rare liver disease characterized by an unclear driver of inflammation, is historically challenged by limited clinical understanding, a slow development of treatment options in investigation, and a nonetheless concerning prognosis for affected adults and children.
While some prospects are in development to aid specialists in adequately...2023-10-2515 minLungcastRSV Wrap-up: Transmission, Testing & Timing of Vaccinations with Dr. Barbara TaylorWith cases of Respiratory Syncytial Virus (RSV) on the rise this fall, Dr. Barbara Taylor, professor of infectious diseases at UT Health San Antonio, joins us for this timely episode all about RSV. Importantly, she covers the unprecedented events of the 2022-2023 season that was marred by a ‘tripledemic’ of respiratory diseases. How do the lessons learned change the preventive approach to better protect against the deadly infection?
Episode Highlights
0:16 Intro
0:48 The burden of RSV today
2:11 Transmission, presentation and diagnosis of RSV
4:33 Likelihood of an RSV, COVID-19, flu “triple-demic”
7:35 The history of RSV vaccin...2023-09-1838 minLungcastMedical Truth-isms of Pulmonary Embolisms with Dr. Parth RaliPulmonary vascular disease expert Dr. Parth Rali at Temple Lung Center helps break down what is known about massive and submassive pulmonary emboli (PE), namely blood clots. This episode provides a comprehensive overview of PE, from the complications of diagnosis to the evolution of therapeutic modalities.
Episode highlights
0:16 Intro
2:34 Defining pulmonary embolism classifications
8:18 The Pulmonary Embolism Severity Index
15:47 The role of D-dimer in diagnosis
17:08 Anticoagulation strategies
22:26 The Pulmonary Embolism Multidisciplinary Response Team
25:38 Long-term outlooks for acute PE
31:38 When to stop anticoagulation
35:27 The future of PE diagnosis and treatment
38:50...2023-09-0539 min
HCPLive PodcastsCOVID-19 Cases Are Climbing, with Donald Alcendor, PhDAfter a historically low-transmission summer, new cases, hospitalizations and deaths due to COVID-19 have increased by approximately 18% in the US over the last week, according to CDC data.
In a new DocTalk interview, Donald J. Alcendor, PhD, associate professor, department of pathology microbiology and immunology, division of infectious diseases, Vanderbilt University Medical Center, and HCPLive Editorial Advisory Board member, discussed the factors influencing the current iteration of COVID-19 in the US. Put briefly: “The virus is changing, and immunity is waning.”
Want more COVID-19 and health care news updates? Visit us at HCPLive.com.
Epis...2023-09-0134 minLungcastLeading the Long Game for Long COVID Research with Dr. Julia Moore VogelIn this must-listen episode, Dr. Julia Moore Vogel at Scripps Research takes center stage to confer the still-emerging and always-evolving space of long COVID. As patient numbers continue to rise at an alarming rate, she makes a strong case about the critical need to better define the disease, mitigate its impact and, ultimately, break the taboo.
Episode highlights
0:15 Introduction
1:27 Moore Vogel’s background in Long Covid
4:30 Lacking terminology in Long Covid
6:20 Quantifying Long Covid disease
8:38 The mechanism of action: what we know
10:27 Pediatric Long Covid
16:00 Similarities to post-viral syndromes
16:58 Key di...2023-07-1729 minLungcastPoor Air Quality Across the US: What You Need to KnowAmid mass poor air quality exposure due to ongoing Canadian wildfires, Lungcast host and ALA Chief Medical Officer Albert Rizzo, MD, explains air quality index (AQI), signs and symptoms of acute and long-term poor air exposure, high-risk patient populations, and the concerning future of particle pollution exposure.
Want more Lungcast? Visit us at HCPLive.com or Lung.org.
Episode Highlights
0:15 Intro
1:23 What is the Air Quality Index?
3:14 Risk factors of poor air quality
4:30 Acute signs and symptoms
6:42 Recommendations for patients with pre-existing conditions
8:09 How long will this last?
10:28 When...2023-06-0814 minLungcastLive From ATS 2023 with Dr. Anne DixonAnne Dixon, MD, Director of Pulmonary and Critical Care Medicine at University of Vermont Medical Center and the first repeat guest in the history of Lungcast, rejoins American Lung Association Chief Medical Officer Albert Rizzo, MD, on the floor at the American Thoracic Society (ATS) 2023 International Conference in Washington, DC, to discuss headline news from the annual meeting and her ongoing work in clinical airway research.
Want more Lungcast? Visit us at HCPLive.com or Lung.org.
Episode Highlights
0:15 Intro
1:00 Obesity burdens in asthma
3:22 Weight loss intervention data at ATS 2023
4:53 ALA grants...2023-05-2614 minLungcastWhere Allergy and Asthma Intersect with Dr. Payel GuptaJust in time for May’s Asthma and Allergy Awareness Month, allergist and immunologist Dr. Payel Gupta of LifeMD.com headlines a conversation about the clinical presentation of asthma and its role in the atopic march. She also details various phenotypes, endotypes and other molecular mechanisms of asthma that can be applied to help guide disease management and treatment decisions.
Episode highlights
0:15 Intro
1:16 Introducing Payel Gupta, MD
2:31 Classifications of asthma
5:35 What is the atopic march?
8:46 The bridge from allergy testing to immunotherapy
12:00 How to initially diagnose asthma
16:02 When to add secondary th...2023-05-1634 minHCPLive PodcastsA First Look at New Insight with Veeral Sheth, MDThe latest offering from HCPLive Podcasts is New InSight with Veeral Sheth, MD, an in-depth series examining the biggest news in ophthalmology. The podcast will feature conversations on research news and new therapies, landmark findings from major medical meetings, and the day-to-day life of an ophthalmologist in the 21st century. A range of guests will join Dr. Sheth to share perspective and provide new insight into an ever-changing and ever-growing field. Stay tuned for our first episodes set to be released in April. But, for now, enjoy this first look at New InSight! 2023-03-3106 minLungcastThoracic Surgeons on the Lung Cancer Team with Dr. David Tom CookeDavid Tom Cooke, MD, Founding Chief of the Division of General Thoracic Surgery at UC Davis, joins the first episode of 2023 to discuss his colleague’s specific role in lung cancer screening and intervention, advances to minimally invasive, robotic and bronchoscopic techniques, and evolving strategies in individualized patient care.
Episode Highlights
0:14 Intro
1:52 Introducing David T. Cooke, MD
3:23 The role of thoracic surgeons in improving lung cancer screening rates
6:22 Shared decision making in thoracic surgery
8:16 Lobar, wedge resection or segmentectomy? Plus, robotic techniques?
12:22 PET/CT scans in the staging process
13:52 The surgeon ap...2023-02-0925 minLungcastThe Air We Breathe: Risks of Poor Indoor Air Quality with Drs. Edward Brooks & Charlene McEvoyAmong many unintended and unexpected effects of sheltering in place during the COVID-19 pandemic is the substantial increase in exposures to indoor allergens and pollutants.
Here, Dr. Edward Brooks at University of Texas at San Antonio and Dr. Charlene McEvoy at University of Minnesota bring a shared expertise on air quality health and research to discuss the resulting health ramifications.
It is an enlightening conversation about the patient populations who are most impacted, plus what can be done to help mitigate the consequences.
Episode highlights
0:16 The history of indoor air environments
2:50 Introducing...2022-11-1626 min
HCPLive PodcastsArshad Khanani, MD: A Breakthrough in Geographic Atrophy TreatmentOne of the most notable topics discussed at the 2022 American Academy of Ophthalmology Meeting in Chicago was new advancements in geographic atrophy (GA) treatment.
A form of advanced age-related macular degeneration (AMD), there are no currently available treatments for the debilitating disease.
In this episode of DocTalk, we spoke with Arshad Khanani, MD, Director of Clinical Research, Sierra Eye Associates, on the findings from the GATHER2 trial on avacincaptad pegol for the treatment of GA.
Throughout our conversation, Khanani laid out the first-time efficacy results of the phase 3 trial and its patient population, the o...2022-10-1412 min
HCPLive PodcastsHeart Team: Making Ground on Women's Cardiovascular Health with Martha Gulati, MDMartha Gulati, MD, Director of Preventive Cardiology, Associate Director of the Barbara Streisand Women’s Heart Center, Associate Director of Preventive and Cardiac Rehabilitation at Cedars-Sinai Medical Center, joins Heart Team to discuss current challenges in women’s cardiovascular disease research and clinical advancement.
Gulati also provides guidance on improving female trial enrollment strategies and patient recruitment, and her thoughts on clinician perception of cardiovascular symptoms in men versus women.
Heart Team is a monthly multimedia series hosted by Jorge Plutzky, MD, Director of Preventive Cardiology at Harvard Medical School, and Michael Farkouh, MD, Director of the...2022-10-0523 minLungcastCrowdsourcing Data to Improve Interstitial Lung Disease Outcomes with Elizabeth Estes & Dr. Simon Walsh
Episode highlights
0:16 Alan Turing and the advent of artificial intelligence
2:19 Challenges and needs in IPF
3:13 Introducing Simon Walsh, MD, and Elizabeth Estes
3:58 Evolving IPF diagnostics
7:31 Multidisciplinary teams and centers for IPF
9:52 OSIC’s use of AI and deep learning in IPF
12:36 The inception of OSIC
17:09 Pursuing AI opportunities in pulmonology
21:03 Applying data to clinical research
27:06 Project Opus
33:20 Final thoughts
37:21 Outro
For additional news and insights into respiratory health, be sure to visit us at HCPLive.com and Lung.org.
2022-09-2138 min
LungcastDeconstructing Obstructive Sleep Apnea with Dr. Reena MehraModern obstructive sleep apnea presents an under met challenge in pulmonary health. This episode, featuring Dr. Reena Mehra at Cleveland Clinic, delves into the ins and outs of this surprisingly common disease that is practically defined by its hefty symptom burden. Listen in to learn more about sleep apnea’s improved diagnostics and advancing therapies, as well as the role of comorbid conditions.
Episode highlights
0:16 The origin of sleep apnea diagnosis
1:48 Current sleep apnea burden in the US
3:16 Defining obstructive sleep apnea
4:40 The OSA pathophysiology
8:36 Clinical characteristics of OSA
11:16 Role of head an...2022-08-0339 minHCPLive PodcastsThe Biggest Discussions in Retina from the 2022 ASRS Annual MeetingThis past week, the American Society of Retina Specialists (ASRS) held its 40th Annual Meeting in New York City to discuss landmark data and the newest advancements in retina care.
The HCPLive team was on-site at the Javits Center in Manhattan conducting interviews with expert retina specialists on topics including drugs for neovascular age-related macular degeneration and geographic atrophy, as well as landmark trials including the phase 3 TENAYA and LUCERNE.
On this episode of DocTalk, we share the biggest highlights and the biggest news from our conversations at the meeting with 5 expert clinicians. 2022-07-2013 minLungcastInnovations in Interventional Pulmonology with Dr. Carla LambDr. Carla Lamb at Beth Israel Lahey Health joins us to discuss her role in developing early interventional pulmonary training and recommendations, the utility of key diagnostic tools in the subspecialty, evolving roles for lung cancer treatments including bronchial stents, modernized COPD intervention and research, and the future of interventional pulmonary medicine. It is an information-packed interview!
Episode highlights
0:16 Intro
1:49 The history of the interventional pulmonology subspecialty
7:12 The Rescue Lung, Rescue Life Society
10:04 Technological advances to low-dose CT scan accuracy
17:04 Utility of bronchial stents in lung cancer care
21:55 Bronchial thermoplasty in asthmatic patients
26:01 Assessing a COPD patient...2022-06-2743 minHCPLive PodcastsSleeping Through Infectious Disease and the COVID-19 VaccineAfter presenting at the SLEEP 2022 annual meeting, Dr. Aric Prather explains the findings of his previous research demonstrated lack of sleep (6 hours or less) was associated with a 4 times higher risk of becoming sick after exposure to rhinovirus in an interview with HCPLive. Currently, Prather and his team at UCSF are working with a large naive population for a study that began in March 2021. They've been able to evaluate various aspects of health by following individuals through the COVID-19 vaccination and booster process. According to Prather, the aim is to identify psychological, behavioral, sleep, and biological predictors of who mounts...2022-06-1421 min
HCPLive PodcastsMulti-System Approaches to Treating Pediatric MorpheaIn recognition of National Scleroderma Awareness Month, HCPLive spoke with several prominent dermatologists today who addressed some of the concerns and advancements related to the rare, multi-system disease.
Scleroderma is often referred to as “morphea” by dermatologists, and the condition typically presents with the tightening and hardening of the skin. Depending on the region of the body, it can result in everything from swollen joints to lesions on the face, arms, and midsection.
For this episode of DocTalk, Karan Lal, DO, MS, FAAD, Schweiger Dermatology Group and member of The Society for Pediatric Dermatology , returned to the program to sp...2022-06-0909 minLungcastModern Asthma Care & SMART Strategy with Drs. Juan Carlos Cardet & Elliot IsraelIn recognition of May’s Asthma Awareness Month, this episode highlights our conversation with Dr. Juan Carlos Cardet at University of South Florida and Dr. Elliot Israel at Brigham and Women’s Hospital about the most common respiratory disease in the U.S. It provides a deep dive into the guideline-supported SMART strategy, role of COVID-19 in current asthma risks, and research into the medical and financial impacts of asthma on the U.S. patient population.
Episode highlights
0:16 The Discovery of Asthma
2:12 Introducing Elliot Israel, MD, and Juan Carlos Cardet, MD, MPH
3:20 Defining the SMART asthma strategy
5:46 The...2022-05-1632 minHCPLive PodcastsA Medical Volunteer at the Ukraine-Poland Refugee BorderToday's episode features Selena S. Li, MD, a Massachusetts General Hospital surgery resident, who recently traveled overseas with a volunteer medical group to provide treatments and care to refugees escaping the Russian invasion.
For more clinical news and expert interviews, visit us at HCPLive.com.
To learn more about donating to or volunteering with Medical Volunteers International, click here.
2022-05-1011 minLungcastSarcoidosis Treatment Landscape & Diagnostic Hurdles with Dr. Mehdi MirsaeidiThe Director of the ILD and Sarcoidosis Program at the Jacksonville College of Medicine joins Dr. Al Rizzo during Sarcoidosis Awareness Month to review the challenges and research surrounding the rare inflammatory disease.
Episode highlights
0:16 The history of sarcoidosis
1:54 Introducing Mehdi Mirsaeidi, MD, MPH
2:54 Understanding inflammatory process in sarcoidosis
5:01 How advanced sarcoidosis presents in clinics
8:34 Anti-inflammatories for sarcoidosis
12:10 The role of lung transplantation
14:27 COVID-19 complications among patients
16:42 The sarcoidosis specialty care team
18:13 Clinical research endeavors
19:36 Outro
For additional news and insights, visit us at HCPLive.com and Lung.org. 2022-04-2520 min
HCPLive PodcastsDiagnosing and Treating Rosacea : An OverviewApril is Rosacea Awareness Month!
While the cause of rosacea is still unknown, what is known is that it is estimated to affect up to 16 million people in the United States alone.
Additionally, a recent survey by the National Rosacea Society indicated that 47% of affect patients were unaware of the disorder prior to their diagnosis, and 95% stated that they knew very little about the signs and symptoms of rosacea.
This Friday, HCPLive will be hosting a variety of discussions and new investigations regarding rosacea in an effort to raise awareness of the condition.
For this e...2022-04-0411 minLungcastGene Editing: Making the Impossible Possible with Drs. Eric Kmiec & Natalia Rivera-TorresFor decades, scientists have hypothesized about a future when diseases could be treated with gene editing techniques. The reality is getting closer to fruition! In this fascinating episode, Drs. Eric Kmiec and Natalia Rivera-Torres at ChristianaCare’s Gene Editing Institute share the latest developments in DNA alteration and explain why CRISPR gene editing continues to offer the most promise.
They also detail how their lab’s pioneering work in squamous cell carcinoma is leading to what will be the first-ever lung cancer patient trial using CRISPR gene editing in a solid tumor.
Learn more about lung cance...2022-03-1643 minHCPLive PodcastsThe Promise of FT218 Therapy for Narcolepsy Patients
How has sleep medicine changed in recent years, and what does the future hold? These are questions that are being asked this week at the World Sleep 2022 congress in Rome, Italy, and new data presented at the conference by Avadel Pharmaceuticals could provide a answers for patients struggling from narcolepsy.
A new post-hoc analyses for the sodium oxybate FT218 found that the therapy improved daytime sleepiness, sleep quality, and refreshing nature of sleep in patients with narcolepsy. It’s safety and efficacy was well established in the ongoing RESTORE study and the REST-ON trial, with participants receiving therapy fo...2022-03-1508 minHCPLive PodcastsImproving the Healthcare System for African American PatientsAt HCPLive, we’ve had the incredible privilege of speaking with doctors from a variety of different clinical fields as well as different cultural, racial, and ethnic backgrounds. Without their dedication, insights, and generosity, the health care system and the world at large would be at a loss.
Even publications such as our own benefit from their work in a myriad of ways. In this episode of DocTalk, we offer listeners a glimpse of some of the most memorable and insightful interviews regarding skin of color, health inequities, and how clinical fields such as dermatology and rheumatology can improve car...2022-02-2413 minLungcastFighting Disparities in Pediatric Asthma Care with Dr. LeRoy GrahamContinuing Black History Month, esteemed pediatric pulmonologist Dr. LeRoy Graham of Bridge Atlanta Medical Center drops by to discuss the disparities that continue to exist in childhood asthma. With a 40-plus history helping underserved communities, this easy-to-digest episode hits many high points about improving access to asthma care.
Learn more about lung cancer screening at HCPLive.com and Lung.org.2022-02-2215 minHCPLive PodcastsHow Rheumatology Patients Should Be Vaccinated for COVID-19In early February, the American College of Rheumatology (ACR) announced an updated version of its COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and Musculoskeletal Diseases.
This update - the fifth of its kind- featured support for booster and supplemental doses in addition to recommendations regarding the timing of the injection as well as immunomodulatory medication use.
Revisions were also made regarding pre- and post-exposure prophylaxis with monoclonal antibody treatment, which are still supported by the guidance despite some limitations being issued by the US Food and Drug Administration.
In a statement made on the day of...2022-02-1615 minLungcastThe Troubling Cycle of Sickle Cell Disease with Dr. Ify OsunkwoIn recognition of Black History Month, we are joined byinternationally acclaimed sickle cell disease expert Dr. Ify Osunkwo at Atrium Health to address stigma, mistrust and disparities. Born in Nigeria, she shares her unique perspectives on the genesis of this genetic disorder and its inequitable public health impacts. Check out the episode for an interesting overview of a storied disease.
Learn more about lung cancer screening at HCPLive.com and Lung.org.2022-02-0735 min
LungcastCurrent State of COPD with Dr. Gerard CrinerFor the first episode of 2022, we welcome Dr. Gerald Criner at Temple University to summarize key highlights of recent clinical trials and research studies in the COPD field. Additionally, he outlines his work on the development of non-surgical techniques for patients who have advanced COPD. What have been the greatest impacts? Hurdles? Listen and learn.
Learn more about lung cancer screening at HCPLive.com and Lung.org.2022-01-2426 minHCPLive PodcastsDetailing Current Flu Vaccine Research with Keipp Talbot, MD, MPHWith the Centers for Disease Control and Prevention observing a steady increase in influenza cases early in the year, the subject of influenza vaccination has become increasingly prevalent.
Keipp Talbot, MD, MPH, Associate Professor of Medicine in the Division of Infectious Diseases at Vanderbilt University, sat down with HCPLive managing editor Kevin Kunzmann to discuss the most recent vaccine innovations that could come to influenza products.
2022-01-1213 minLungcastLung Cancer Screening: Trials, Tribulations & Triumphs with Dr. James MulshineIn recognition of Lung Cancer Awareness Month, this episode featuring Dr. James Mulshine at Rush University explains the ins and outs of the improved 2021 lung cancer screening guidelines. While a big step in the right direction, complexities and challenges of equitable access to low-dose CT scans continue to persist, plus the profound impact of the COVID-19 pandemic on screening rates.
Learn more about lung cancer screening at HCPLive.com and Lung.org.2021-11-2235 minLungcastInterstitial Lung Disease: Scratching Beneath the Surface with Dr. Marilyn GlassbergInterstitial lung disease, which prominently includes idiopathic pulmonary fibrosis, is a very broad category of chronic lung conditions with considerable nuance. To help break it down within the context of diagnosis and treatment, Dr. Marilyn Glassberg at University of Arizona joins us to discuss the roles of biomarkers, biopsies and drugs. This episode also sheds light on multidisciplinary clinics and stem cell therapy.
Learn more about ILD and IPF at HCPLive.com and Lung.org.2021-10-1931 min
HCPLive PodcastsRanibizumab PDS, Faricimab, Gene Therapy and Top ASRS 2021 HeadlinesJosh Mali, MD, of The Eyes Associates, joins HCPLive to review the key news and developments coming out of the American Society of Retina Specialists 2021 Scientific Meeting.2021-10-0922 min
LungcastBiologic Breakthroughs for Severe Asthma with Dr. Mario CastroDr. Castro and Dr. Rizzo discuss the evolving world of monoclonal antibodies for the treatment of severe asthma. Plus, the ALA team discusses September's annual Asthma Peak Week, and what it means for reopening schools.
See and read more Lungcast recaps and additional interviews at HCPLive.com/sap-partner/american-lung-association.
Listen to Dr. Rizzo's interview with Dr. Anne Dixon on the 2020 asthma management guidelines here.
Visit Lung.org for more resources and expert insights into respiratory disease management.
Episode highlights
0:15 Back to school with Asthma Peak Week
9:48 Biologics: the emerging severe asthma treatment...2021-09-0845 min
Tribo TDAHTribo TDAH - TDAH Explica #07 - COVID-19 causa TDAH? Quais efeitos no transtorno? (Parte 2)Olá, bem-vindo à Tribo TDAH, o podcast com hiperfoco na sua vida!
No sétimo episódio da nossa nova série TDAH Explica vamos terminar de falar sobre a pandemia de COVID-19, seus efeitos no Transtorno de Déficit de Atenção e Hiperatividade e também desmistificamos a discussão sobre sintomas e efeitos pós-covid similares ao TDAH.
#TDAH
#TDAHpodcasters
#PcDPodcasters
#OPodcastÉDelas
#MulheresPodcasters
---
**Seja um TDAHyper e ajude a Tribo TDAH a crescer!**
- Tribo TDAH no Apoia.se https://apoia.se/tribotdah
- Tribo TDAH no PicPay https://picpay.me/triboTDAH
---
**Links de referência**
- ADHD focus...2021-06-0353 min
Tribo TDAHTribo TDAH - TDAH Explica #06 - COVID-19 causa TDAH? Quais efeitos no transtorno? (Parte 1)Olá, bem-vindo à Tribo TDAH, o podcast com hiperfoco na sua vida!
No sexto episódio da nossa nova série TDAH Explica falamos sobre a pandemia de COVID-19, seus efeitos no Transtorno de Déficit de Atenção e Hiperatividade e também desmistificamos a discussão sobre sintomas e efeitos pós-covid similares ao TDAH.
#TDAH
#TDAHpodcasters
#PcDPodcasters
#OPodcastÉDelas
#MulheresPodcasters
---
**Seja um TDAHyper e ajude a Tribo TDAH a crescer!**
- Tribo TDAH no Apoia.se https://apoia.se/tribotdah
- Tribo TDAH no PicPay https://picpay.me/triboTDAH
---
**Links de referência**
- ADHD focus concerns covid-19...2021-05-2740 min
LungcastCOVID-19 Double Lung Transplant with Ankit Bharat, MDThe chief of thoracic surgery and surgical director of the Northwestern Medicine Lung Transplant Program discusses his unprecedented procedure during the pandemic, and what the current state of thoracic surgery looks like across diseases.2020-09-0942 min
HCPLive PodcastsThe State of Preventive Cardiology2020-08-2725 minHCPLive PodcastsReturning to Sports During COVID-19Dr. Louis Kovacs and Dr. Evan Lipson discuss the risk of playing youth, college, and professional sports during the ongoing pandemic.2020-08-1429 min
HCPLive PodcastsGeorge Everly, PhD: The Mental Health Burdens of COVID-19George Everly, PhD, discusses some of the pitfalls people face due to the ongoing pandemic. 2020-08-0525 minLungcastCOVID-19 Complications & Searches for a Cure with Dr. David HoHIV/AIDS pioneer and Time 1996 Man of the Year Dr. David Ho joins for a discussion on the shortcomings of the US pandemic response, the race for a vaccine, other research pursuits, and the similarities between the HIV and COVID-19 epidemics.2020-08-0449 min
HCPLive PodcastsGene Therapy for X-Linked Retinitis Pigmentosa2020-07-2520 minLungcastWelcome to LungcastA preview of what's to come on Lungcast, a deep-dive interview series on the greatest topics of respiratory health.2020-07-2202 min
HCPLive PodcastsMark Smith, MD, Phd: The Anxiousness of Coming Out of QuarantineIn the latest edition of the DocTalk Podcast, Dr. Mark Smith talks about some of the issues related to the COVID-19 lockdown and how a second wave might psychologically impact individuals.2020-05-2722 min
HCPLive PodcastsBiologics for Inflammatory Care, COVID-19 ResearchDr. Ian Pavord discusses new meta-analyses of dupilumab planned for ATS 2020.2020-05-1825 min
HCPLive PodcastsCOVID-19 Health InequityPanagis Galiatsatos, MD, MHS, joins to discuss the underlying issues and potential solutions to COVID-19 patient disparities.2020-05-1123 min
HCPLive PodcastsDaniel Kiernan, MD: Dexycu for Inflammation Post-Vitreoretinal SurgeryDiscussing a would-be ARVO 2020 presentation examining the use of anterior chamber intracameral dexamethasone drug-delivery suspen for postoperative inflammation in patients undergoing vitreoretinal surgery.2020-05-0705 min
HCPLive PodcastsComparing GLP-1 Receptor Agonists with SGLT2 Inhibitors for Type 2 Diabetes PatientsInvestigators from Saint Louis University discuss their recent study comparing GLP-1 receptor agonists with SGLT2 inhibitors.2020-04-1217 min
HCPLive PodcastsTezepelumab for Atopic DiseasesClinical investigator and allergist Jonathan Corren, MD, shares insight on the TSLP inhibitor.2020-04-1015 min
HCPLive PodcastsRespiratory Health During COVID-19Al Rizzo, MD, CMO of the American Lung Association, discusses some of the biggest challenges and questions raised on lung health during the coronavirus pandemic.2020-04-0620 min
HCPLive PodcastsDupilumab for Severe Pediatric Atopic DermatitisAmy S. Paller, MD, principal investigator of the phase 3 LIBERTY AD PEDS trial, discusses the add-on biologic's benefit for young patients and potential as a pediatrc allergic therapy.2020-04-0413 min
HCPLive PodcastsDr. Kaneko: PLO FLOW TAVR, July Effect, & Alternative Access TAVRDr. Kaneko, a cardiac surgeon at Brigham and Women's Hospital, breaks down a trio of studies he was associated with from ACC.20, including a look into PLO FLOW TAVR, the July Effect, and alternative access TAVR.2020-04-0312 min
HCPLive PodcastsRivaroxaban With and Without Clopidogrel for PAD w/ Dr. Bonaca2020-03-2902 min
HCPLive PodcastsKausik Ray, MD: Inclisiran for ASCVDThe ORION-11 principal investigator highlights new LDL-C reduction findings and teases future research for the siRNA-targeting drug.2020-03-2819 minHCPLive PodcastsVOYAGER-PAD Results w/ Dr. Marc Bonaca2020-03-2802 min